FOXA1
برای مطالعهٔ بیشتر

Song L, Xu Z, Zhang C,  et al. (2009). "Up-regulation of the HSP72 by Foxa1 in MCF-7 human breast cancer cell line". Biochem. Biophys. Res. Commun. 386 (1): 30–4. doi:10.1016/j.bbrc.2009.05.120. PMID 19486887.
Zhang Y, Ali TZ, Zhou H,  et al. (2010). "ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer". Cancer Res. 70 (1): 240–8. doi:10.1158/0008-5472.CAN-09-2904. PMC 3724404. PMID 20048076.
McMullin RP, Dobi A, Mutton LN,  et al. (2010). "A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland". Proc. Natl. Acad. Sci. U.S.A. 107 (1): 98–103. doi:10.1073/pnas.0902001107. PMC 2806740. PMID 20018680.
Sun Q, Yu X, Degraff DJ, Matusik RJ (2009). "Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expression". Mol. Endocrinol. 23 (12): 2038–47. doi:10.1210/me.2009-0092. PMC 2796152. PMID 19846536.
Liu N, Niu Y, Wang SL,  et al. (2010). "[Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas]". Zhonghua Yi Xue Za Zhi. 90 (20): 1403–7. PMID 20646630.
Haiman CA, Garcia RR, Hsu C,  et al. (2009). "Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort". BMC Cancer. 9: 43. doi:10.1186/1471-2407-9-43. PMC 2637888. PMID 19183483.
Kohler S, Cirillo LA (2010). "Stable chromatin binding prevents FoxA acetylation, preserving FoxA chromatin remodeling". J. Biol. Chem. 285 (1): 464–72. doi:10.1074/jbc.M109.063149. PMC 2804194. PMID 19897491.
Malik S, Jiang S, Garee JP,  et al. (2010). "Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM". Mol. Cell. Biol. 30 (2): 399–412. doi:10.1128/MCB.00907-09. PMC 2798473. PMID 19917725.
Motallebipour M, Ameur A, Reddy Bysani MS,  et al. (2009). "Differential binding and co-binding pattern of FOXA1 and FOXA3 and their relation to H3K4me3 in HepG2 cells revealed by ChIP-seq". Genome Biol. 10 (11): R129. doi:10.1186/gb-2009-10-11-r129. PMC 3091322. PMID 19919681.
Eeckhoute J, Lupien M, Meyer CA,  et al. (2009). "Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers". Genome Res. 19 (3): 372–80. doi:10.1101/gr.084582.108. PMC 2661808. PMID 19129543.
Nakshatri H, Badve S (2007). "FOXA1 as a therapeutic target for breast cancer". Expert Opin. Ther. Targets. 11 (4): 507–14. doi:10.1517/14728222.11.4.507. PMID 17373880.
Iacobazzi V, Infantino V, Bisaccia F,  et al. (2009). "Role of FOXA in mitochondrial citrate carrier gene expression and insulin secretion". Biochem. Biophys. Res. Commun. 385 (2): 220–4. doi:10.1016/j.bbrc.2009.05.030. PMID 19445897.
Nucera C, Eeckhoute J, Finn S,  et al. (2009). "FOXA1 is a potential oncogene in anaplastic thyroid carcinoma". Clin. Cancer Res. 15 (11): 3680–9. doi:10.1158/1078-0432.CCR-08-3155. PMID 19470727.
Nakshatri H, Badve S (2009). "FOXA1 in breast cancer". Expert Rev Mol Med. 11: e8. doi:10.1017/S1462399409001008. PMID 19261198.
Song Y, Washington MK, Crawford HC (2010). "Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer". Cancer Res. 70 (5): 2115–25. doi:10.1158/0008-5472.CAN-09-2979. PMC 2831111. PMID 20160041.
Lee HJ, Chattopadhyay S, Yoon WH,  et al. (2010). "Overexpression of hepatocyte nuclear factor-3alpha induces apoptosis through the upregulation and accumulation of cytoplasmic p53 in prostate cancer cells". Prostate. 70 (4): 353–61. doi:10.1002/pros.21069. PMID 19866472.
Bernardo GM, Lozada KL, Miedler JD,  et al. (2010). "FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis". Development. 137 (12): 2045–54. doi:10.1242/dev.043299. PMC 2875844. PMID 20501593.
Albergaria A, Paredes J, Sousa B,  et al. (2009). "Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours". Breast Cancer Res. 11 (3): R40. doi:10.1186/bcr2327. PMC 2716509. PMID 19549328.
Huang QY, Li GH, Kung AW (2009). "The -9247 T/C polymorphism in the SOST upstream regulatory region that potentially affects C/EBPalpha and FOXA1 binding is associated with osteoporosis". Bone. 45 (2): 289–94. doi:10.1016/j.bone.2009.03.676. PMID 19371798.
Sano M, Aoyagi K, Takahashi H,  et al. (2010). "Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis". Int. J. Oncol. 36 (2): 321–30. doi:10.3892/ijo_00000503. PMID 20043065.